Beam Therapeutics Inc. (BEAM) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$139.7M

Net Income/Loss (FY2025)

-$80.0M

Total Assets (FY2025)

$1.5B

Total Equity (FY2025)

$1.2B

Cash Flows from Operating Activities (FY2025)

-$345.1M

Source: Beam Therapeutics Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.